SeekingAlpha · Mar 5, 2026
SH
NASDAQ · SHSAX
BlackRock Health Sciences Opportunities Portfolio Investor A Shares
Public company research
$66.50
Down-$0.14 (-0.21%)
Updated Aug 25, 2026, 8:54 AM
SID Score
5.2/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 5.86B
- P/E ratio
- —
- Dividend yield
- 11.54%
- 52-week range
- — – —
- Volume
- 0
- Avg. volume
- 0
Price performance
SHSAX price history
1M range · 0 trading sessions · Daily adjusted prices
SHSAX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest SHSAX news
The latest Smart Investors Daily articles mentioning SHSAX.
Stock researchCompany · Overview
SHSAX research
Overview
Company profile and research snapshot.
Company profile
The investment seeks to provide long-term growth of capital. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Jan 6, 2026
BlackRock Health Sciences Opportunities Fund Q3 2025 Commentary
BlackRock Health Sciences Opportunities Fund posted returns of 5.04%Â (Institutional shares) and 4.96%Â (Investor A shares, without sales charge) for Q3 2025.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
